Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR.
Saved in:
| Title: | Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR. |
|---|---|
| Authors: | Cholon, Deborah M1 (AUTHOR), Aleksandrov, Luba A1 (AUTHOR), Quinney, Nancy L1 (AUTHOR), Boyles, Susan E1 (AUTHOR), Jensen, Timothy J1 (AUTHOR), Aleksandrov, Andrei A1,2 (AUTHOR), Gentzsch, Martina1,3,4 (AUTHOR) gentzsch@med.unc.edu |
| Source: | Science Progress. Oct-Dec2025, Vol. 108 Issue 4, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00368504 |
|---|---|
| DOI: | 10.1177/00368504251384892 |
